ʻO ka PCR Fluorescence
-
Influenza A Virus/ Influenza B Virus
Hoʻohana ʻia kēia pahu no ka ʻike kūpono o ka maʻi influenza A a me ka maʻi influenza B RNA i loko o nā laʻana oropharyngeal swab kanaka.
-
ʻEono ʻAi ʻAi ʻAha
Hoʻohana ʻia kēia kit no ka ʻike qualitative o respiratory syncytial virus (RSV), adenovirus (Adv), human metapneumovirus (hMPV), rhinovirus (Rhv), parainfluenza virus type I/II/III (PIVI/II/III), a me Mycoplasma pneumoniae (MP) nucleic acids i loko o nā laʻana oropharyngeal swab samples.
-
Hantaan Virus Nucleic
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o ka hantavirus hantaan type nucleic acid i nā laʻana serum.
-
ʻO Xinjiang Hemorrhagic Fever Virus
Hiki i kēia pahu ke ʻike qualitative o Xinjiang hemorrhagic fever virus nucleic acid i nā laʻana serum o nā poʻe maʻi i manaʻo ʻia me Xinjiang hemorrhagic fever, a hāʻawi i ke kōkua i ka hōʻoia ʻana o nā maʻi me Xinjiang hemorrhagic fever.
-
ʻO ka maʻi maʻi Encephalitis nahele
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o ka ululāʻau encephalitis virus nucleic acid i nā laʻana serum.
-
ALDH Genetic Polymorphism
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka ALDH2 gene G1510A polymorphism pūnaewele i loko o ke kanaka peripheral blood genomic DNA.
-
11 Nā ʻano o ka maʻi maʻi hanu
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o nā pathogens respiratory clinical maʻamau i loko o ka sputum kanaka, me Haemophilus influenzae (HI), Streptococcus pneumoniae (SP), Acinetobacter baumannii (ABA), Pseudomonas aeruginosa (PA), Klebsiella Pneumoniae (KPN), Stenotrophomonassis maltophilia (BP) parapertusss (Bpp), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), Legionella pneumophila (Leg). Hiki ke hoʻohana ʻia nā hopena ma ke ʻano he kōkua i ka ʻike ʻana i nā maʻi maʻi maʻi maʻi a i ʻole maʻi koʻikoʻi me nā maʻi maʻi bacterial o ka ʻōpū hanu.Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o nā pathogens respiratory clinical maʻamau i loko o ka sputum kanaka, me Haemophilus influenzae (HI), Streptococcus pneumoniae (SP), Acinetobacter baumannii (ABA), Pseudomonas aeruginosa (PA), Klebsiella Pneumoniae (KPN), Stenotrophomonassis maltophilia (BP) parapertusss (Bpp), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), Legionella pneumophila (Leg). Hiki ke hoʻohana ʻia nā hopena ma ke ʻano he kōkua i ka ʻike ʻana i nā maʻi maʻi maʻi maʻi a i ʻole maʻi koʻikoʻi me nā maʻi maʻi bacterial o ka ʻōpū hanu.
-
Ka hoʻololi ʻana o ke kanaka PML-RARA Fusion Gene
Hoʻohana ʻia kēia kit no ka ʻike qualitative o PML-RARA fusion gene i loko o nā ʻāpana iwi iwi kanaka i vitro.
-
14 Nā ʻano maʻi hanu i hui ʻia
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka coronavirus novel (SARS-CoV-2), ka maʻi Influenza A (IFV A), ka maʻi Influenza B (IFV B), ka maʻi maʻi hanu hanu (RSV), Adenovirus (Adv), metapneumovirus kanaka (hMPV), rhinovirus (Rhv), ʻano maʻi virus Parainfluenza/IV/IV (PIIV) kanaka. (HBoV), Enterovirus (EV), Coronavirus (CoV), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), a me Streptococcus pneumoniae (SP) nucleic acids i loko o ke kanaka oropharyngeal swab a me nasopharyngeal swab samples.
-
Orientia tsutsugamushi
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o ka nucleic acid o Orientia tsutsugamushi i nā laʻana serum.
-
ʻO ka Mycobacterium Tuberculosis Nucleic Acid a me Rifampicin(RIF), Kūʻē (INH)
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o Mycobacterium tuberculosis DNA i loko o ke kanaka sputum, ka moʻomeheu paʻa (LJ Medium) a me ka moʻomeheu wai (MGIT Medium), ka wai holoi bronchial, a me nā hoʻololi ʻana i ka 507-533 amino acid codon region (81bp, rifampicin resistance determining region) o ka rpoifampicin kūʻē kūʻokoʻa ʻāpana o ka pūnaeʻa o ka rpoifampic as well. i loko o nā kahua mutation nui o Mycobacterium tuberculosis isoniazid resistance.It hāʻawi i ke kōkua i ka hōʻoia o Mycobacterium tuberculosis maʻi, a ia ike i ka nui kū'ē genes o rifampicin a me isoniazid, e kokua i ka hoomaopopo ana i ka lāʻau kū'ē o Mycobacterium tuberculosis maʻi e ka mea maʻi.
-
ʻAno maʻi polio Ⅲ
He kūpono kēia pahu no ka ʻike qualitative o ka poliovirus Type Ⅲ nucleic acid i loko o nā mea hoʻohālike o ke kanaka i loko o ka vitro.
